Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Medical Supplies
myzeno.com

See what CB Insights has to offer

Founded Year

2002

Stage

Unattributed VC - II | Alive

Total Raised

$52M

Last Raised

$4M | 11 yrs ago

About Zeno

Zeno Corporation is a Houston-based medical technology company engaged in the development of products using its patented ClearPoint technologyˆ as well as other products related to skin care.

Zeno Headquarter Location

12600 Northborough Suite 250

Houston, Texas, 77067,

United States

281-880-6541

Latest Zeno News

Amelia Brandt appointed SVP of purpose and impact at Zeno

Jun 22, 2021

Added 2 hours ago by Aleda Stam The agency also named leaders to employee engagement and DEI roles. Brandt will be responsible for advising in environmental, social and governance, social impact and purpose. She is one of three recent hires to lead areas of strategic growth at Zeno: DEI, purpose and employee engagement. The firm also hired Anne DeAngelis as EVP of employee engagement strategy, based in Chicago. She is reporting to Mark Shadle, MD of corporate affairs. DeAngelis (above) is charged with advising clients on employer branding, recruitment communications, employee experience strategies, change management and return-to-office dynamics. In April, the firm brought on Andréa Richardson as EVP of DEI, helping Zeno and its clients achieve commitments to being more diverse and inclusive. Both Brandt and Richardson are reporting to Alison DaSilva, MD of purpose and impact. Brandt has joined Zeno from Porter Novelli, where she was a VP in the firm's purpose practice. She created global corporate responsibility platforms and campaigns, conducted materiality assessments, consulted on a variety of ESG issues and developed some of the most regarded corporate responsibility reports in the industry. For more than 20 years, DeAngelis worked at Boeing in Seattle and Chicago in several director-level positions, including corporate and digital communications and global brand management and advertising. Richardson most recently co-led the DEI practice at Finsbury Glover Hering. She has also worked at Hilton, where she counseled in multicultural marketing and diversity strategy. Last month, Zeno released its most recent round of DE&I numbers , with CEO Barby Siegel describing the improvement as "progress with a small 'p.’”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Zeno Patents

Zeno has filed 18 patents.

The 3 most popular patent topics include:

  • Analgesics
  • Phenols
  • Piperidines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/9/2019

4/13/2021

Analgesics, Phenols, Amines, Piperidines, Synthetic opioids

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/9/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/13/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Analgesics, Phenols, Amines, Piperidines, Synthetic opioids

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.